Trials / Unknown
UnknownNCT04161690
Evaluation of Dexketoprofen in Total Knee Arthroplasty
Evaluation of Dexketoprofen Given Intravenous or Intrathecal in Postoperative Pain in Patients Undergoing Total Knee Arthroplasty
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 120 (estimated)
- Sponsor
- KAT General Hospital · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Accepted
Summary
Pain is a global public health issue and represents the most common reason for both physician consultation and hospital admissions. Dexketoprofen is a new NSAID treating acute postoperative pain. The purpose of this study is to evaluate the analgesic effect when it is given intravenously or as part of the local infiltration analgesia in patients under spinal anesthesia undergoing unilateral total knee arthroplasty.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Dexketoprofen Trometamol | intravenous dexketoprofen 50mg or intrathecal |
| DRUG | Ropivacaine Hydrochloride 7.5 MG/ML | Local Infiltration Analgesia |
Timeline
- Start date
- 2019-11-06
- Primary completion
- 2020-11-30
- Completion
- 2021-11-30
- First posted
- 2019-11-13
- Last updated
- 2019-11-13
Locations
1 site across 1 country: Greece
Source: ClinicalTrials.gov record NCT04161690. Inclusion in this directory is not an endorsement.